合計 50 件の最近のインサイダー取引記録が記録されています Icosavax, Inc. (ICVX), 内訳は 14 件の買い および 36 件の売り. インサイダー買い総額は $11.14M インサイダー売り総額は $16.02M.
最近活動のある主要インサイダーには Fields Heidi, Mcdade Mark, Ra Capital Management, L.p.. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ICVX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-02-19 |
Fields Heidi |
Other: See Remarks |
株式返還 |
17,000 |
$9.89 |
$168.13K |
- |
| 2024-02-19 |
Mcdade Mark |
Other: See Remarks |
株式返還 |
17,000 |
$9.89 |
$168.13K |
- |
| 2024-02-19 |
Ra Capital Management, L.p. |
10 Percent Owner |
株式返還 |
17,000 |
$9.89 |
$168.13K |
- |
| 2024-02-19 |
Veneman Ann M |
Other: See Remarks |
株式返還 |
25,500 |
$15.00 |
$382.5K |
- |
| 2024-02-19 |
Russo Thomas Joseph |
Other: See Remarks |
TOB（売り） |
39,367 |
$15.00 |
$590.51K |
- |
| 2024-02-19 |
Wassil Jim |
Other: See Remarks |
株式返還 |
17,000 |
$9.89 |
$168.13K |
- |
| 2024-02-19 |
Simpson Adam K. |
Other: See Remarks |
株式返還 |
317,866 |
$17.55 |
$5.58M |
- |
| 2024-02-19 |
Cearley Cassia |
Other: See Remarks |
株式返還 |
89,400 |
$17.55 |
$1.57M |
- |
| 2024-02-19 |
Kanesa-thasan Niranjan |
Other: See Remarks |
株式返還 |
81,950 |
$17.55 |
$1.44M |
- |
| 2024-02-19 |
Shiver John W. |
Other: See Remarks |
株式返還 |
25,500 |
$22.50 |
$573.75K |
- |
| 2024-02-19 |
Khan Amin |
Other: See Remarks |
株式返還 |
180,000 |
$10.16 |
$1.83M |
- |
| 2024-02-01 |
Simpson Adam K. |
Chief Executive Officer |
オプション行使（売却） |
15,000 |
$1.04 |
$15.6K |
191,449 |
| 2024-01-22 |
Simpson Adam K. |
Chief Executive Officer |
オプション行使（売却） |
4,789 |
$0.84 |
$4.02K |
- |
| 2024-01-02 |
Simpson Adam K. |
Chief Executive Officer |
情報に基づく売り |
15,000 |
$15.67 |
$235.09K |
260,641 |
| 2023-12-21 |
Simpson Adam K. |
Chief Executive Officer |
オプション行使（売却） |
23,343 |
$0.84 |
$19.61K |
4,789 |
| 2023-12-20 |
Russo Thomas Joseph |
Chief Financial Officer |
情報に基づく売り |
4,430 |
$15.47 |
$68.51K |
38,037 |
| 2023-12-20 |
Simpson Adam K. |
Chief Executive Officer |
情報に基づく売り |
62,205 |
$15.46 |
$961.51K |
184,724 |
| 2023-12-20 |
Cearley Cassia |
Chief Business Officer |
情報に基づく売り |
7,934 |
$15.46 |
$122.64K |
130,694 |
| 2023-12-20 |
Kanesa-thasan Niranjan |
Chief Medical Officer |
情報に基づく売り |
11,884 |
$15.46 |
$183.69K |
223,980 |
| 2023-12-13 |
Cearley Cassia |
Chief Business Officer |
情報に基づく売り |
8,759 |
$16.01 |
$140.19K |
131,200 |
| 2023-08-01 |
Simpson Adam K. |
Chief Executive Officer |
オプション行使（売却） |
3,000 |
$0.84 |
$2.52K |
28,132 |
| 2023-07-31 |
Russo Thomas Joseph |
Chief Financial Officer |
情報に基づく売り |
3,066 |
$8.86 |
$27.17K |
45,620 |
| 2023-07-31 |
Simpson Adam K. |
Chief Executive Officer |
情報に基づく売り |
11,788 |
$8.86 |
$104.46K |
243,930 |
| 2023-07-31 |
Cearley Cassia |
Chief Business Officer |
情報に基づく売り |
1,888 |
$8.86 |
$16.73K |
139,959 |
| 2023-07-31 |
Kanesa-thasan Niranjan |
Chief Medical Officer |
情報に基づく売り |
3,323 |
$8.86 |
$29.45K |
235,864 |
| 2023-07-03 |
Holtzman Douglas |
Chief Scientific Officer |
オプション行使（売却） |
16,356 |
$1.04 |
$17.01K |
28,621 |
| 2023-06-12 |
Khan Amin |
EVP, Head of Research & Dev. |
処分 |
120,000 |
$9.06 |
$1.09M |
- |
| 2023-06-12 |
Khan Amin |
EVP, Head of Research & Dev. |
RSU 付与（制限付株式） |
180,000 |
$10.16 |
$1.83M |
180,000 |
| 2023-06-06 |
Fields Heidi |
Director |
RSU 付与（制限付株式） |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Mcdade Mark |
Director |
RSU 付与（制限付株式） |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Ra Capital Management, L.p. |
10 Percent Owner |
RSU 付与（制限付株式） |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Veneman Ann M |
Director |
RSU 付与（制限付株式） |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Wassil Jim |
Director |
RSU 付与（制限付株式） |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-06-06 |
Shiver John W. |
Director |
RSU 付与（制限付株式） |
17,000 |
$9.89 |
$168.13K |
17,000 |
| 2023-05-23 |
Cearley Cassia |
Chief Business Officer |
情報に基づく売り |
10,000 |
$10.00 |
$100K |
141,847 |
| 2023-04-03 |
Holtzman Douglas |
Chief Scientific Officer |
オプション行使（売却） |
20,443 |
$1.04 |
$21.26K |
44,977 |
| 2023-03-06 |
Cearley Cassia |
Chief Business Officer |
情報に基づく売り |
5,000 |
$7.75 |
$38.74K |
151,847 |
| 2023-02-15 |
Simpson Adam K. |
Chief Executive Officer |
オプション行使 |
10,677 |
$1.04 |
$11.1K |
255,718 |
| 2023-02-15 |
Russo Thomas Joseph |
Chief Financial Officer |
RSU 付与（制限付株式） |
125,000 |
$9.06 |
$1.13M |
125,000 |
| 2023-02-15 |
Simpson Adam K. |
Chief Executive Officer |
RSU 付与（制限付株式） |
350,000 |
$9.06 |
$3.17M |
350,000 |
| 2023-02-15 |
Cearley Cassia |
Chief Business Officer |
RSU 付与（制限付株式） |
140,000 |
$9.06 |
$1.27M |
140,000 |
| 2023-02-15 |
Kanesa-thasan Niranjan |
Chief Medical Officer |
RSU 付与（制限付株式） |
110,000 |
$9.06 |
$996.6K |
110,000 |
| 2023-02-15 |
Holtzman Douglas |
Chief Scientific Officer |
RSU 付与（制限付株式） |
90,000 |
$9.06 |
$815.4K |
90,000 |
| 2023-02-15 |
Bekiroglu Elizabeth |
General Counsel & Corp. Sec. |
RSU 付与（制限付株式） |
100,000 |
$9.06 |
$906K |
100,000 |
| 2023-02-14 |
Holtzman Douglas |
Chief Scientific Officer |
情報に基づく売り |
3,349 |
$10.17 |
$34.06K |
290,054 |
| 2023-02-13 |
Russo Thomas Joseph |
Chief Financial Officer |
情報に基づく売り |
1,902 |
$10.69 |
$20.34K |
48,686 |
| 2023-02-13 |
Simpson Adam K. |
Chief Executive Officer |
情報に基づく売り |
7,506 |
$10.69 |
$80.26K |
245,041 |
| 2023-02-13 |
Cearley Cassia |
Chief Business Officer |
情報に基づく売り |
1,660 |
$10.69 |
$17.75K |
156,847 |
| 2023-02-13 |
Kanesa-thasan Niranjan |
Chief Medical Officer |
情報に基づく売り |
1,794 |
$10.69 |
$19.18K |
239,187 |
| 2023-02-13 |
Holtzman Douglas |
Chief Scientific Officer |
情報に基づく売り |
1,522 |
$10.69 |
$16.27K |
293,403 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
